• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ESW
Click for more information
0.00% 15.0¢

EMERSON STEWART GROUP LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ESW
Ann: Change of Director's Interest Notice 		30/11/11 0 246
30/11/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  246 
ESW
Ann: Results of Meeting 		30/11/11 0 253
30/11/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  253 
ESW
Ann: Chairman's Address to Shareholders 		30/11/11 0 257
30/11/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  257 
ESW
Ann: Change in substantial holding 		29/11/11 0 299
29/11/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  299 
ESW
Ann: Change in substantial holding 		18/11/11 0 272
18/11/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  272 
ESW
Ann: Change of Director's Interest Notice 		18/11/11 0 185
18/11/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  185 
ESW
Ann: Non Renounceable Entitlement Issue Allotment 		03/11/11 0 216
03/11/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  216 
ESW
Ann: Initial Director's Interest Notice 		02/11/11 0 251
02/11/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  251 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.